The structure and biochemistry of NADH-dependent cytochrome b5 reductase are now consistent

被引:71
作者
Bewley, MC [1 ]
Marohnic, CC
Barber, MJ
机构
[1] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA
[2] Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
关键词
D O I
10.1021/bi0106336
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Cytochrome b(5) reductase (cb5r) (EC 1.6.6.2) catalyzes the reduction of two molecules of cytochrome b(5) using NADH as the physiological electron donor. The structure of pig cb5r at 2.4 Angstrom resolution was previously reported in the literature, but it was inconsistent with the biochemistry; for example, K83 and C245 were both implicated in the mechanism, but were not located at the active site. To address this problem, we have determined the structures of cb5r from rat at 2.0 Angstrom resolution and in a complex with NAD(+) at 2.3 Angstrom resolution. We found significant differences throughout the rat structure compared to that of pig, including the locations of the lysine and cysteine residues mentioned above. To test the structural models, we made single amino acid substitutions of this lysine and showed that all substitutions produced correctly folded proteins and exhibited normal flavin behavior. However, the apparent k(cat)(NADH) decreased, and the apparent Km for NADH increased; the K-m's for cytochrome b(5) were unchanged relative to that of the wild type. The largest effect was for the glutamate-substituted protein, which was further characterized using a charge transfer assay and found to be less efficient at NADH utilization than the wild type. These results are consistent with a role for this lysine in stabilizing the NADH-bound form of cb5r. We have concluded that the pig structure was mistraced in several regions and have reinterpreted mutants in these regions that give rise to the hereditary disease methemoglobinemia.
引用
收藏
页码:13574 / 13582
页数:9
相关论文
共 43 条
[1]
IDENTIFICATION OF LYS116 AS THE TARGET OF N-ETHYLMALEIMIDE INACTIVATION OF FERREDOXIN - NADP+ OXIDOREDUCTASE [J].
ALIVERTI, A ;
GADDA, G ;
RONCHI, S ;
ZANETTI, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 198 (01) :21-24
[2]
High-level expression in Escherichia coli of the soluble, catalytic domain of rat hepatic cytochrome b(5) reductase [J].
Barber, MJ ;
Quinn, GB .
PROTEIN EXPRESSION AND PURIFICATION, 1996, 8 (01) :41-47
[3]
Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[4]
PHTHALATE DIOXYGENASE REDUCTASE - A MODULAR STRUCTURE FOR ELECTRON-TRANSFER FROM PYRIDINE-NUCLEOTIDES TO [2FE-2S] [J].
CORRELL, CC ;
BATIE, CJ ;
BALLOU, DP ;
LUDWIG, ML .
SCIENCE, 1992, 258 (5088) :1604-1610
[5]
*DAR LAB, 1991, SRC UK COLL COMP PRO
[6]
Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b5 reductase gene leading to methemoglobinemia type I [J].
Dekker, J ;
Eppink, MHM ;
van Zwieten, R ;
de Rijk, T ;
Remacha, AF ;
Law, LK ;
Li, AM ;
Cheung, KL ;
van Berkel, WJH ;
Roos, D .
BLOOD, 2001, 97 (04) :1106-1114
[7]
Deng Z, 1999, NAT STRUCT BIOL, V6, P847
[8]
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities [J].
Esnouf, RM .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 1997, 15 (02) :132-+
[9]
HACKETT CS, 1988, J BIOL CHEM, V263, P7539
[10]
EVIDENCE FOR PARTICIPATION OF CYTOCHROME B5 IN HEPATIC MICROSOMAL MIXED-FUNCTION OXIDATION REACTIONS [J].
HILDEBRANDT, A ;
ESTABROOK, RW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1971, 143 (01) :66-+